A Joint Venture between Canary Wharf Group and Kadans Science Partner has received the green light from Tower Hamlets Council for their plans to establish a 23-storey vertical campus at the heart of a new world class life sciences ecosystem.

The 23-storey 823,000 sq ft tower development will contain a state-of-the-art commercial health and life sciences building at the North Quay site, adjacent to the Crossrail Station and new Elizabeth Line at Canary Wharf, London.

Shobi Khan, CEO of Canary Wharf Group, said: “This is a significant milestone in our development of a world-class life sciences hub at Canary Wharf.  While the North Quay development is an integral focal point, we have been working in tandem to nurture and grow our current life sciences community and we have built real momentum this year through leasing success and working with our partners Kadans to develop bespoke and innovative new facilities.  The next chapter in the evolution of Canary Wharf is well underway with the next generation of health and life science companies set to become a significant presence in our sustainable, mixed-use environment.”

Enabling works on the 3.3 hectare site are already well underway and the building is anticipated to complete in 2027 and will be a world-leading centre for health and life sciences. 

Michel Leemhuis, CEO of Kadans Science Partner, added: “In addition to its scale, location and technology, this building sets a new benchmark in its field for sustainability, capitalizing on our previous experience and lessons learned, while engaging industry working groups to ensuring we are delivering a facility tailor-made to industry requirements.  With planning consent secured, we are looking forward to continuing the extraordinary progress we are making with the Canary Wharf Group.”